HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Donald D. Glower J. Scott Rankin Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glower, D. D. Articles by Rankin, J. S. Search for Related Content PubMed PubMed Citation Articles by Glower, D. D. Articles by Rankin, J. S. Related Collections Valve disease

J Thorac Cardiovasc Surg 2005;129:860-868
© 2005 The American Association for Thoracic Surgery

Surgery for Acquired Cardiovascular Disease

Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation

^a Duke University Medical Center, Durham, NC
^b Centennial Medical Center, Nashville, Tenn
^c Vanderbilt University, Nashville, Tenn.

Received for publication May 4, 2004; revisions received October 17, 2004; accepted for publication November 17, 2004.

^_* Address for reprints: Donald D. Glower, MD, Duke University Medical Center, Box 3851, Durham, NC 27710. (E-mail: glowe001{at}mc.duke.edu).

BACKGROUND: Ischemic mitral regurgitation has been associated with diminished survival compared with nonischemic mitral regurgitation. Conversion from mitral valve replacement to valve repair has improved prognosis, but it is unclear whether ischemic mitral regurgitation remains an independent predictor of outcome after mitral valve repair.

METHODS: Five hundred thirty-five patients undergoing mitral valve repair (primarily rigid ring annuloplasty) with or without coronary bypass from 1993 through 2002 were reviewed retrospectively (ischemic mitral regurgitation, n = 141; nonischemic mitral regurgitation, n = 394). A Cox proportional hazards model evaluated survival as a function of 9 simultaneous covariates: ischemic versus nonischemic mitral regurgitation, age, sex, number of medical comorbidities, ejection fraction, New York Heart Association class, coronary disease, reoperation, and year of operation.

RESULTS: According to univariable analysis, patients with ischemic mitral regurgitation had greater age, higher comorbidity, lower ejection fraction, higher New York Heart Association, and higher reoperation rate (all P < .001) compared with those having nonischemic mitral regurgitation. Univariable 30-day mortality was as follows: 4.3% for patients with ischemic mitral regurgitation versus 1.3% for patients with nonischemic mitral regurgitation (P = .01). Unadjusted 5-year mortality was as follows: 44% ± 5% for patients with ischemic mitral regurgitation versus 16% ± 3% for patients with nonischemic mitral regurgitation (P < .001). In the multivariable model, however, only the number of preoperative comorbidities and advanced age were independent predictors of survival (P < .0001), whereas ischemic mitral regurgitation, sex, ejection fraction, New York Heart Association class, coronary disease, reoperation, and year of operation did not achieve significance (all P > .19). After being adjusted for differences in all preoperative risk factors, survival was not statistically different between ischemic mitral regurgitation and nonischemic mitral regurgitation (P = .33).

CONCLUSIONS: With routine application of rigid ring annuloplasty, long-term patient survival is more influenced by baseline patient characteristics and comorbidity than by ischemic cause of mitral regurgitation per se. Future risk assessment and decision making should be based on patient condition and should not be biased by ischemic cause of mitral regurgitation.

This article has been cited by other articles:

				P. Kolh Surgical correction of ischaemic mitral regurgitation still a long way to go Eur. Heart J., January 2, 2008; 29(2): 147 - 149. [Full Text] [PDF]

				J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text]

				L. M. Gazoni, J. A. Kern, B. R. Swenson, J. M. Dent, P. W. Smith, D. P. Mulloy, T. B. Reece, L. M. Fedoruk, T. C. Lisle, B. B. Peeler, et al. A Change in Perspective: Results for Ischemic Mitral Valve Repair Are Similar to Mitral Valve Repair for Degenerative Disease Ann. Thorac. Surg., September 1, 2007; 84(3): 750 - 758. [Abstract] [Full Text] [PDF]

				J. J. Jokinen, M. J. Hippelainen, O. A. Pitkanen, and J. E.K. Hartikainen Mitral Valve Replacement Versus Repair: Propensity-Adjusted Survival and Quality-of-Life Analysis Ann. Thorac. Surg., August 1, 2007; 84(2): 451 - 458. [Abstract] [Full Text] [PDF]

				M.-A. Rey Meyer, L. K. von Segesser, M. Hurni, F. Stumpe, K. Eisa, and P. Ruchat Long-term outcome after mitral valve repair: a risk factor analysis Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 301 - 307. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF]

				Pitfalls and limitations in measuring and interpreting the outcomes of mitral valve repair. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 523 - 529.

				Determinants of operative mortality in valvular heart surgery. J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 547 - 557.

				A. M. Gillinov, E. H. Blackstone, J. Rajeswaran, M. Mawad, P. M. McCarthy, J. F. Sabik III, T. Shiota, B. W. Lytle, and D. M. Cosgrove Ischemic Versus Degenerative Mitral Regurgitation: Does Etiology Affect Survival? Ann. Thorac. Surg., September 1, 2005; 80(3): 811 - 819. [Abstract] [Full Text] [PDF]